Martin Burke: The smart synthesizer

Credit: © Nick Burchell" /> Credit: © Nick Burchell In November 1998, Martin Burke was on his first clinical rotation in the MD/PhD program at Harvard Medical School when he met a 22-year-old cystic fibrosis patient who was taking 17 different medications. Knowing that a single missing chloride channel causes the disease, it bothered Burke that the treatment comprised such a large cocktai

Written byElie Dolgin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In November 1998, Martin Burke was on his first clinical rotation in the MD/PhD program at Harvard Medical School when he met a 22-year-old cystic fibrosis patient who was taking 17 different medications. Knowing that a single missing chloride channel causes the disease, it bothered Burke that the treatment comprised such a large cocktail of drugs. It struck him immediately that science might be able to replace the missing ion channel in the same way that a prosthetic limb replaces a lost leg. "I wanted to develop prostheses on the molecular scale," he says.

As far back as Burke can remember, he wanted to become either a major league baseball player or a doctor. Unfortunately, baseball didn't pan out. So, as an undergraduate at Johns Hopkins University in 1994, he enrolled in pre-med courses, including an introductory organic chemistry class that would change his life. There, he met Christina White, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies